AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine
Journal of Inflammation Research · 2023-11 · Volume 16 · 5451-5464
DOI: 10.2147/jir.s441597 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Inflammation Research, 2023-11. Verfasst von Changxing Liu und 3 weiteren Autor:innen. Beteiligte Einrichtung: First Clinical Medical School, Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 127 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- First Clinical Medical School, Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China.
- Clinical Medical School, Chengdu University of Traditional Chinese Medicine, Chengdu, 610075, People's Republic of China.
- Department of Cardiology, The First Hospital of Heilongjiang University of Chinese Medicine, Harbin, 150040, People's Republic of China.
Zitieren
APA
Liu, C., Guo, X., Zhou, Y., & Wang, H. (2023). AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine. Journal of Inflammation Research, Volume 16, 5451-5464. https://doi.org/10.2147/jir.s441597
Vancouver
Liu C, Guo X, Zhou Y, Wang H. AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine. Journal of Inflammation Research. 2023;Volume 16:5451-5464. doi:10.2147/jir.s441597
BibTeX
@article{Liu2023,
author = {Liu, Changxing and Guo, Xinyi and Zhou, Yabin and Wang, He},
title = {AMPK Signalling Pathway: A Potential Strategy for the Treatment of Heart Failure with Chinese Medicine},
journal = {Journal of Inflammation Research},
year = {2023},
volume = {Volume 16},
pages = {5451--5464},
doi = {10.2147/jir.s441597}
}
EUVIMED